Literature DB >> 18992784

Classifying mood disorders by age-at-onset instead of polarity.

Franco Benazzi1.   

Abstract

BACKGROUND: Polarity is the pillar of the current categorical unipolar-bipolar division of mood disorders. However, genetic studies on these polarity-based phenotypes have been largely inconclusive. Recent clinical and epidemiological studies seem to support more of a continuum than a splitting of mood disorders. A reshaping of the classification of mood disorders thus seems required. Age-at-onset and recurrence have been suggested to be more clinically and genetically useful in the phenotyping of mood disorders. STUDY AIM: To test a classification of mood disorders based on age-at-onset, and to delineate its phenotypes.
METHODS: A total of 441 consecutive bipolar II disorder (BP-II) and 289 unipolar major depressive disorder (MDD) outpatients, presenting for treatment of a major depressive episode (MDE) in a clinical and research private practice, were assessed by a mood disorder specialist psychiatrist (FB) using a Structured Clinical Interview for the DSM-IV, modified for better probing past hypomania [Benazzi, F. Bipolar disorder-focus on bipolar II disorder and mixed depression. Lancet 2007a;369: 935-945]. The sample was divided according to age-at-onset. Age-at-onset was defined by the age at onset of the first MDE. Early-age-at-onset (EO) was defined as age at onset before 21 years, late-age-at-onset (LO) as onset at or after age 21 years. The study's current goal had not been planned when data were recorded between 1999 and 2006. Variables were compared in EO versus LO mood disorders, investigating phenotype differences. The main focus was on 'classic' diagnostic validators: MDE clinical picture, gender, course, and family history. Age, gender, BP-II, and mania/hypomania family history (possible confounding) were controlled for in the analyses. Logistic regression was used.
RESULTS: First, EO was regressed on each variable, one at a time, to find significant associations. Second, EO was regressed on all of the variables whose odds ratio (OR) was statistically significant in the previous analyses in order to find independent predictors. Independent predictors of EO mood disorder were history of hypomania, high recurrence, atypical depression, and family history of mania/hypomania. Controlling for BP-II (in addition to age and gender) did not impact the findings. The highest OR was that between EO and high recurrence (OR=4.00). Distinguishing MDE symptoms of EO mood disorder included hypersomnia and psychomotor agitation when controlling for age and gender, and, by controlling also for BP-II, hypersomnia only. DISCUSSION: A close association among EO mood disorder, high recurrence, and bipolarity (history of hypomania, family history of mania/hypomania) was found. Compared to most previous studies testing EO versus LO in bipolar (mainly BP-I) or in unipolar MDD samples, the present study tested a mixed BP-II and MDD sample and controlled for polarity, reducing, as much as possible, the impact of polarity on the findings. EO (below age 21 years) was distinguished by hypersomnic depression, high recurrence, high history of hypomania, and high history of mania/hypomania. Replications are needed, especially in mixed samples also including BP-I. Results, if replicated, could have implications not only for clinical and genetic studies, but also for treatment (e.g., mood stabilizers could have better long-term effects than antidepressants in EO mood disorders, antidepressants could have negative long-term effects on EO).

Entities:  

Mesh:

Year:  2008        PMID: 18992784     DOI: 10.1016/j.pnpbp.2008.10.007

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  15 in total

Review 1.  Activated depression: mixed bipolar disorder or agitated unipolar depression?

Authors:  Alan C Swann
Journal:  Curr Psychiatry Rep       Date:  2013-08       Impact factor: 5.285

2.  Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life.

Authors:  Katja Beesdo; Michael Höfler; Ellen Leibenluft; Roselind Lieb; Michael Bauer; Andrea Pfennig
Journal:  Bipolar Disord       Date:  2009-09       Impact factor: 6.744

3.  Case records of the Massachusetts General Hospital. Case 16-2013. A 12-year-old girl with irritability, hypersomnia, and somatic symptoms.

Authors:  Suzanne L Bender; Nicole A Sherry; Ricard Masia
Journal:  N Engl J Med       Date:  2013-05-23       Impact factor: 91.245

4.  Differences between early and late onset adult depression.

Authors:  Jens Drachmann Bukh; Camilla Bock; Maj Vinberg; Ulrik Gether; Lars Vedel Kessing
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-08-10

5.  Does age at onset of first major depressive episode indicate the subtype of major depressive disorder?: the clinical research center for depression study.

Authors:  Seon-Cheol Park; Sang-Woo Hahn; Tae-Yeon Hwang; Jae-Min Kim; Tae-Youn Jun; Min-Soo Lee; Jung-Bum Kim; Hyeon-Woo Yim; Yong Chon Park
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

6.  Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group.

Authors:  L Schmaal; D J Veltman; T G M van Erp; P G Sämann; T Frodl; N Jahanshad; E Loehrer; H Tiemeier; A Hofman; W J Niessen; M W Vernooij; M A Ikram; K Wittfeld; H J Grabe; A Block; K Hegenscheid; H Völzke; D Hoehn; M Czisch; J Lagopoulos; S N Hatton; I B Hickie; R Goya-Maldonado; B Krämer; O Gruber; B Couvy-Duchesne; M E Rentería; L T Strike; N T Mills; G I de Zubicaray; K L McMahon; S E Medland; N G Martin; N A Gillespie; M J Wright; G B Hall; G M MacQueen; E M Frey; A Carballedo; L S van Velzen; M J van Tol; N J van der Wee; I M Veer; H Walter; K Schnell; E Schramm; C Normann; D Schoepf; C Konrad; B Zurowski; T Nickson; A M McIntosh; M Papmeyer; H C Whalley; J E Sussmann; B R Godlewska; P J Cowen; F H Fischer; M Rose; B W J H Penninx; P M Thompson; D P Hibar
Journal:  Mol Psychiatry       Date:  2015-06-30       Impact factor: 15.992

7.  Demographic and Diagnostic Features of 3147 Inpatients With Mood Disorders in Iran.

Authors:  Atefeh Ghanbari Jolfaei; Pari Ghadamgahi; Masoud Ahmadzad-Asl; Amir Shabani
Journal:  Iran J Psychiatry Behav Sci       Date:  2016-08-14

8.  Neurocognitive features in subgroups of bipolar disorder.

Authors:  Sofie Ragnhild Aminoff; Tone Hellvin; Trine Vik Lagerberg; Akiah Ottesen Berg; Ole A Andreassen; Ingrid Melle
Journal:  Bipolar Disord       Date:  2013-03-25       Impact factor: 6.744

9.  Age of onset of mood disorders and complexity of personality traits.

Authors:  L Ostacoli; M Zuffranieri; M Cavallo; A Zennaro; I Rainero; L Pinessi; M V Pacchiana Parravicini; E Ladisa; P M Furlan; R L Picci
Journal:  ISRN Psychiatry       Date:  2013-04-23

10.  Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group.

Authors:  L Schmaal; D P Hibar; P G Sämann; G B Hall; B T Baune; N Jahanshad; J W Cheung; T G M van Erp; D Bos; M A Ikram; M W Vernooij; W J Niessen; H Tiemeier; A Hofman; K Wittfeld; H J Grabe; D Janowitz; R Bülow; M Selonke; H Völzke; D Grotegerd; U Dannlowski; V Arolt; N Opel; W Heindel; H Kugel; D Hoehn; M Czisch; B Couvy-Duchesne; M E Rentería; L T Strike; M J Wright; N T Mills; G I de Zubicaray; K L McMahon; S E Medland; N G Martin; N A Gillespie; R Goya-Maldonado; O Gruber; B Krämer; S N Hatton; J Lagopoulos; I B Hickie; T Frodl; A Carballedo; E M Frey; L S van Velzen; B W J H Penninx; M-J van Tol; N J van der Wee; C G Davey; B J Harrison; B Mwangi; B Cao; J C Soares; I M Veer; H Walter; D Schoepf; B Zurowski; C Konrad; E Schramm; C Normann; K Schnell; M D Sacchet; I H Gotlib; G M MacQueen; B R Godlewska; T Nickson; A M McIntosh; M Papmeyer; H C Whalley; J Hall; J E Sussmann; M Li; M Walter; L Aftanas; I Brack; N A Bokhan; P M Thompson; D J Veltman
Journal:  Mol Psychiatry       Date:  2016-05-03       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.